Zenas BioPharma, Inc. Payments to Acquire Investments
Zenas BioPharma, Inc. (ZBIO) reported Payments to Acquire Investments of $408.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-13
- Zenas BioPharma, Inc. payments to acquire investments for the quarter ending 2026-06-30 was $331.81M, a 162.19% increase year-over-year.
- Zenas BioPharma, Inc. payments to acquire investments for the quarter ending 2026-03-31 was $76.52M, a 22.80% decline year-over-year.
- Zenas BioPharma, Inc. payments to acquire investments for the quarter ending 2025-12-31 was $132.89M, a 1275.56% increase year-over-year.
- Zenas BioPharma, Inc. payments to acquire investments for the quarter ending 2025-09-30 was $59.20M.
- Zenas BioPharma, Inc. payments to acquire investments for fiscal 2025 was $417.75M, a 1047.02% increase from fiscal 2024.
- Zenas BioPharma, Inc. payments to acquire investments for fiscal 2024 was $36.42M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $331.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $408.33M 10-Q · filed 2026-08-13 | $541.22M derived: sum of 3 quarters · filed 2026-08-13 | $600.42M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $76.52M 10-Q · filed 2026-05-13 | $209.41M derived: sum of 2 quarters · filed 2026-05-13 | $268.61M derived: sum of 3 quarters · filed 2026-05-13 | $395.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $132.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $192.09M derived: sum of 2 quarters · filed 2026-03-16 | $318.64M derived: sum of 3 quarters · filed 2026-08-13 | $417.75M 10-K · filed 2026-03-16 |
| 2025-09-30 | $59.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $185.75M derived: sum of 2 quarters · filed 2026-08-13 | $284.86M 10-Q · filed 2025-11-12 | $294.52M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $126.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $225.67M 10-Q · filed 2026-08-13 | $235.33M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | $99.11M 10-Q · filed 2026-05-13 | $108.78M derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $9.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $36.42M 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $26.76M 10-Q · filed 2025-11-12 |